Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
about
Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCTChoosing between stem cell therapy and drugs in myelofibrosis.Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.Morphology of the bone marrow after stem cell transplantation.Allogeneic stem cell transplantation as treatment for myelofibrosis.Allogeneic hematopoietic cell transplantation for patients with myelofibrosisSafety of conditioning agents for allogeneic haematopoietic transplantation.Allogeneic stem cell transplantation for myelofibrosis in 2012.Current Challenges in Stem Cell Transplantation in Myelofibrosis.The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study.Fatal hepatic failure associated with graft rejection following reduced-intensity stem-cell transplantation for chronic idiopathic myelofibrosis (CIMF).Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.Long-term remission of myelofibrosis following nonmyeloablative allogeneic peripheral blood progenitor cell transplantation in older age: the Scripps Clinic experience.
P2860
Q33556843-A35CA87B-B5F2-4B48-9E52-EC3DCF1E89F4Q34734491-2EEAF262-806B-4BDA-80AA-E1F8C17EB294Q35196663-71EC4971-D68A-4E78-B7BC-55B341305585Q35608022-8D0BC359-4B75-433A-AFCD-5D7B34171E84Q36182976-93FFD534-8F7F-40AF-87A5-53420374CA5DQ36399935-3BE535DA-D9DD-4C3F-9701-419FEBEB43A6Q36609417-A8461DD7-FB25-464B-B7B9-92DF4E87E66CQ37495397-AB10A388-5A6B-4385-BDAC-89827639CE6BQ37510948-6F9A7E58-8B8F-4CEF-B99A-4E253E433E3BQ37998567-DC9DFE14-9380-4249-B2DE-56C0D08E3406Q38569146-566CD2CA-601D-493B-82B0-C8A21296D6BDQ43162409-ED766642-3509-47A3-BB3B-09376F3C3CFCQ45204139-A02D2D08-3009-4DF4-8693-3307D1297696Q47868737-8EDE1274-C96B-47E3-B1BB-4E15E557F4E6Q49286156-3AD9EF70-3501-4B72-9EAF-E7C990C6D5AC
P2860
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@en
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@nl
type
label
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@en
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@nl
prefLabel
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@en
Dose-reduced conditioning regi ...... rosis with myeloid metaplasia.
@nl
P2093
P2860
P1476
Dose-reduced conditioning regi ...... brosis with myeloid metaplasia
@en
P2093
Arne Hansen
Axel Rolf Zander
Francis Ayuketang Ayuk
Helmut Renges
Jörg Hessling
Jörg Panse
Mathias Werner
Nicolaus Kröger
Rudolf Erttmann
Tatjana Zabelina
P2860
P304
P356
10.1046/J.1365-2141.2002.03884.X
P407
P50
P577
2002-12-01T00:00:00Z